Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
Ascension Ventures
AddedFeb 13, 2024
UpdatedJun 28, 2026
Ascension Ventures

Ascension Ventures

Operating

Ascension Health Ventures: A US-based venture capital firm investing in healthcare services and tech.

Location
London, Greater London, GB
Founded
2011
Firm
Compare
Portfolio
Employees
Website

Investments

Censys
Censys

Total Raised

$128.1M

Rounds

5

Series C$50MOctober 2023
Instylla
Instylla

Total Raised

$63.5M

Rounds

3

Series C$30MAugust 2023
Series B$25.4MOctober 2020
Strive Health
Strive Health

Total Raised

$386M

Rounds

3

Series C$166MMay 2023
Series B$140MMarch 2021
Series A$80MApril 2019
Aiberry
Aiberry

Total Raised

$8M

Rounds

1

Seed$8MMarch 2023
Rejoni
Rejoni

Total Raised

$41.3M

Rounds

2

Series B$26.3MDecember 2022
Elation Health
Elation Health

Total Raised

$108.5M

Rounds

6

Series D$50MJuly 2022
RefleXion Medical
RefleXion Medical

Total Raised

$675.1M

Rounds

11

Series Unknown$80MMarch 2022
Cala Health
Cala Health

Total Raised

$148.3M

Rounds

4

Series D$77MNovember 2021
Imperative Care
Imperative Care

Total Raised

$409M

Rounds

5

Series D$260MJuly 2021
Series C$85MDecember 2019
Renovia
Renovia

Total Raised

$72.3M

Rounds

5

Series C$17MApril 2021
Series B$32.3MAugust 2018
Bind On-Demand Health Insurance
Bind On-Demand Health Insurance

Total Raised

$237.5M

Rounds

5

Series B$105MOctober 2020
Series A$10MJune 2018
Owl Insights
Owl Insights

Total Raised

$16.4M

Rounds

4

Series Unknown$15MSeptember 2020
AristaMD
AristaMD

Total Raised

$53.4M

Rounds

7

Series B$6MJuly 2020
Syapse
Syapse
Public

Total Raised

$222.6M

Rounds

9

Series F$30MMay 2020
Series E$20MJanuary 2019
Cardionomic
Cardionomic

Total Raised

$49.8M

Rounds

4

Series Unknown$15.8MFebruary 2020
Reputation.com
Reputation.com

Total Raised

$210.6M

Rounds

4

Series C$34.9MAugust 2019
CSA Medical
CSA Medical
Public

Total Raised

$106M

Rounds

8

Series Unknown$45.2MFebruary 2019
Olive
Olive
Acquired

Total Raised

$856.3M

Rounds

9

Series D$32.8MJuly 2018